RT Journal Article
T1 Performance of the Medical Research Council (MRC) and the Leukemia Research Foundation (LRF) score in predicting survival benefit with hypomethylating agent use in patients with relapsed or refractory acute myeloid leukemia.
A1 Stahl, Maximilian
A1 DeVeaux, Michelle
A1 Montesinos, Pau
A1 Itzykson, Raphaël
A1 Ritchie, Ellen K
A1 Sekeres, Mikkael A
A1 Barnard, John
A1 Podoltsev, Nikolai A
A1 Brunner, Andrew
A1 Komrokji, Rami S
A1 Bhatt, Vijaya R
A1 Al-Kali, Aref
A1 Cluzeau, Thomas
A1 Santini, Valeria
A1 Roboz, Gail J
A1 Fenaux, Pierre
A1 Litzow, Mark
A1 Fathi, Amir T
A1 Perreault, Sarah
A1 Kim, Tae Kon
A1 Prebet, Thomas
A1 Vey, Norbert
A1 Verma, Vivek
A1 Germing, Ulrich
A1 Bergua, Juan
A1 Serrano, Josefina
A1 Gore, Steven D
A1 Zeidan, Amer M
YR 2018
FD 2018-07-02
LK http://hdl.handle.net/10668/12666
UL http://hdl.handle.net/10668/12666
LA en
DS RISalud
RD Apr 10, 2025